Vista Pharmaceuticals

quarterly
yearly
ParticularsJun '21Sep '21Dec '21Mar '22Jun '22
Revenue0.000.290.110.000.00
Expenses0.591.340.420.460.36
EBITDA-0.59-1.05-0.31-0.46-0.36
EBIT-0.75-1.36-0.46-0.61-0.51
Profit Before Tax-0.76-1.49-0.63-0.44-0.59
Net Profit-0.12-0.66-0.630.46-0.59
Financial Ratios
Operating Profit MarginNA%-365.52%-281.82%NA%NA%
Net Profit MarginNA%-227.59%-572.73%NA%NA%
Earning Per Share (Diluted)-0.03-0.19-0.180.11-0.18
Dividends Per ShareNANANANANA
ⓒ 2016-2022 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 3.3.6
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  ICICI PRUDENTIAL |  HDFC |  NIPPON INDIA |  ADITYA BIRLA SUN LIFE |  SBI |  UTI |  FRANKLIN TEMPLETON |  KOTAK MAHINDRA |  IDFC |  DSP |  AXIS |  TATA |  L&T |  SUNDARAM |  PGIM |  INVESCO |  LIC |  JM FINANCIAL |  BARODA PIONEER |  CANARA ROBECO |  HSBC |  IDBI |  INDIABULLS |  MOTILAL OSWAL |  BNP PARIBAS |  MIRAE ASSET |  PRINCIPAL |  BOI AXA |  UNION KBC |  TAURUS |  EDELWEISS |  NAVI |  MAHINDRA |  QUANTUM |  PPFAS |  IIFL |  Quant |  SHRIRAM |  SAHARA |  ITI